Impact of nab–paclitaxel-based second-line chemotherapy in metastatic pancreatic cancer N Dadi, M Stanley, S Shahda, BH O'NEIL, A Sehdev Anticancer Research 37 (10), 5533-5539, 2017 | 19 | 2017 |
Real-world Data of Leukopenia Evaluation as Seen in a Community Academic Center SS Chennapragada, S Sharma, N Dadi, R Shi, RP Mansour Journal of Community Hospital Internal Medicine Perspectives 13 (6), 126, 2023 | | 2023 |
Evaluation of the Efficacy of Flow-Cytometry in the Work-up of Leukopenia: An Institutional Retrospective Analysis S Chennapragada, N Dadi, R Shi, RP Mansour Blood 140 (Supplement 1), 7893-7894, 2022 | | 2022 |
Outcomes of Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Meta-Analysis N Dadi, V Vosuri, SR Master, RP Mansour Blood 134, 5699, 2019 | | 2019 |
Role of adjuvant chemotherapy in small (≤ 5 mm) node-negative and hormone receptor-negative breast cancer. SR Master, N Dadi, C Shah, GV Burton, R Shi Journal of Clinical Oncology 37 (15_suppl), e12021-e12021, 2019 | | 2019 |
The impact of research presented at annual gastrointestinal cancers symposium. A Sehdev, N Dadi, DA Haggstrom, LG Koniaris, BH O'Neil Journal of Clinical Oncology 36 (4_suppl), 757-757, 2018 | | 2018 |
Impact of nab-paclitaxel-based second-line chemotherapy on the outcomes of pancreatic cancer. N Dadi, S Shahda, BH O'Neil, A Sehdev Journal of Clinical Oncology 35 (4_suppl), 483-483, 2017 | | 2017 |